Evidence map›Paper›PMID 29925362›Full record

ArticleBMC pulmonary medicine2018

Heparin-binding protein in sputum as a marker of pulmonary inflammation, lung function, and bacterial load in children with cystic fibrosis.

Gisela Hovold, Victoria Palmcrantz, Fredrik Kahn, Arne Egesten, Lisa I Påhlman

Open access · goldAbstract read
In one paragraph

Article in BMC pulmonary medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. The dipeptidyl peptidase 1 inhibition landscape in bronchiectasis and its future direction.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  2. [Association between heparin-binding protein and other clinical indicators with the microscopic severity ofZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Gisela HovoldDepartment of Clinical Sciences Lund, Division of Infection Medicine, BMC B14, Lund University, Skåne University Hospital, Tornavägen 10, SE-22184, Lund, Sweden.
Victoria PalmcrantzSkåne University Hospital, Clinic of Paediatrics, Lund, Sweden.
Fredrik KahnDepartment of Clinical Sciences Lund, Division of Infection Medicine, BMC B14, Lund University, Skåne University Hospital, Tornavägen 10, SE-22184, Lund, Sweden.
Arne EgestenDepartment of Clinical Sciences Lund, Respiratory Medicine & Allergology, Lund University, Lund, Sweden.
Lisa I PåhlmanDepartment of Clinical Sciences Lund, Division of Infection Medicine, BMC B14, Lund University, Skåne University Hospital, Tornavägen 10, SE-22184, Lund, Sweden. Lisa.Pahlman@med.lu.se.ORCID http://orcid.org/0000-0001-6366-2309
Lund University · SESkåne University Hospital · SE

Funding

Hjärt-Lungfonden 2013-0376Magnus Bergvalls Stiftelse 2016-01377
6 · The paper itself

Abstract

backgroundCystic fibrosis (CF) is associated with bacterial pulmonary infections and neutrophil-dominated inflammation in the airways. The aim of this study was to evaluate the neutrophil-derived protein Heparin-binding protein (HBP) as a potential sputum marker of airway inflammation and bacterial load.

methodsNineteen CF patients, aged 6-18 years, were prospectively followed for 6 months with sputum sampling at every visit to the CF clinic. A total of 41 sputum samples were collected. Sputum-HBP was analysed with ELISA, neutrophil elastase activity with a chromogenic assay, and total bacterial load with RT-PCR of the 16 s rDNA gene. Data were compared to lung function parameters and airway symptoms.

resultsHBP and elastase correlated to a decrease in FEV

conclusionsSputum HBP is a promising marker of airway inflammation and pulmonary function in children with CF.

Indexed as

Bacterial LoadAntimicrobial Cationic PeptidesBiomarkersBlood ProteinsCarrier ProteinsChildCystic FibrosisFemaleHumansLeukocyte ElastaseLogistic ModelsLungMalePneumoniaProspective StudiesRespiratory Function TestsAntimicrobial Cationic PeptidesAZU1 protein, humanBiomarkersBlood ProteinsCarrier ProteinsLeukocyte ElastaseAirway infectionChildrenCystic fibrosisInflammationLung functionSputum

Identifiers

PMID29925362
PMCPMC6011334
OpenAlexW2809463764

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.